Literature DB >> 30725347

A report on three live births in women with poor ovarian response following intra-ovarian injection of platelet-rich plasma (PRP).

Marzie Farimani1, Safoura Heshmati2, Jalal Poorolajal3,4, Maryam Bahmanzadeh5,6.   

Abstract

The prevalence of poor response to gonadotropin stimulation is approximately 9-24% in women undergoing in vitro fertilization. Interestingly, due to containing a variety of growth factors, platelet-rich plasma (PRP) can play an important role in tissue regeneration and healing. Thus, in this research, we aimed to investigate the intra-ovarian injection of PRP in women with poor ovarian response. To this goal, 23 poor responders constituted the study population, from among whom 19 women were enrolled. These patients underwent ovarian stimulation according to the Shanghai protocol. Immediately after the first follicular puncture, 2 mL of PRP was injected into each ovary. 1 day after the first puncture and PRP injection, the second stimulation was initiated. Then, oocyte retrieval was followed. About 2-3 months after the first cycle, the patients underwent another treatment with ovarian stimulation according to the Shanghai protocol and then, follicular puncture was performed. The mean numbers of oocytes before and after PRP injection were 0.64 and 2.1, respectively. Two patients experienced spontaneous conceptions. The third case achieved clinical pregnancy and delivered a healthy baby in June 2018. The results of this study appeared to be the first report on the effects of intra-ovarian PRP injection on the increase of ovarian responses, even on the spontaneous conceptions of women with poor ovarian response.

Entities:  

Keywords:  Infertility; Ovary; Platelet rich plasma; Poor ovarian response; Pregnancy

Mesh:

Year:  2019        PMID: 30725347     DOI: 10.1007/s11033-019-04609-w

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  37 in total

1.  Perifollicular blood flow Doppler indices, but not follicular pO2, pCO2, or pH, predict oocyte developmental competence in in vitro fertilization.

Authors:  S Huey; A Abuhamad; G Barroso; M I Hsu; P Kolm; J Mayer; S Oehninger
Journal:  Fertil Steril       Date:  1999-10       Impact factor: 7.329

Review 2.  Angiogenesis and its control in the female reproductive system.

Authors:  H M Fraser; S F Lunn
Journal:  Br Med Bull       Date:  2000       Impact factor: 4.291

3.  Gene expression profiling of early follicular development in primordial, primary, and secondary follicles.

Authors:  Se-Jin Yoon; Kyeoung-Hwa Kim; Hyung-Min Chung; Dong-Hee Choi; Woo-Sik Lee; Kwang-Yul Cha; Kyung-Ah Lee
Journal:  Fertil Steril       Date:  2006-01       Impact factor: 7.329

4.  Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles.

Authors:  U A Vitt; M Hayashi; C Klein; A J Hsueh
Journal:  Biol Reprod       Date:  2000-02       Impact factor: 4.285

5.  Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization.

Authors:  C Wulff; S E Dickson; W C Duncan; H M Fraser
Journal:  Hum Reprod       Date:  2001-12       Impact factor: 6.918

Review 6.  In vitro maturation of human primordial ovarian follicles: clinical significance, progress in mammals, and methods for growth evaluation.

Authors:  R Abir; S Nitke; A Ben-Haroush; B Fisch
Journal:  Histol Histopathol       Date:  2006-08       Impact factor: 2.303

7.  Cell-type localization of platelet-derived growth factors and receptors in the postnatal rat ovary and follicle.

Authors:  Leanne S Sleer; Christopher C Taylor
Journal:  Biol Reprod       Date:  2006-11-15       Impact factor: 4.285

Review 8.  Stage-dependent role of growth differentiation factor-9 in ovarian follicle development.

Authors:  U A Vitt; A J Hsueh
Journal:  Mol Cell Endocrinol       Date:  2001-10-25       Impact factor: 4.102

Review 9.  Angiogenesis and vascular function in the ovary.

Authors:  R S Robinson; K J Woad; A J Hammond; M Laird; M G Hunter; G E Mann
Journal:  Reproduction       Date:  2009-09-28       Impact factor: 3.906

10.  Platelet-derived growth factors (PDGF-A and -B) and their receptors in human fetal and adult ovaries.

Authors:  H Pinkas; B Fisch; G Rozansky; C Felz; G Kessler-Icekson; H Krissi; S Nitke; A Ao; R Abir
Journal:  Mol Hum Reprod       Date:  2008-03-07       Impact factor: 4.025

View more
  17 in total

Review 1.  Novel Approaches in Addressing Ovarian Insufficiency in 2019: Are We There Yet?

Authors:  Konstantinos Sfakianoudis; Anna Rapani; Sokratis Grigoriadis; Dimitra Retsina; Evangelos Maziotis; Petroula Tsioulou; Polina Giannelou; Konstantinos Pantos; Michael Koutsilieris; Nikolaos Vlahos; George Mastorakos; Mara Simopoulou
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

Review 2.  Ovarian response to intraovarian platelet-rich plasma (PRP) administration: hypotheses and potential mechanisms of action.

Authors:  Serin Seckin; Hadi Ramadan; Marco Mouanness; Michelle Kohansieh; Zaher Merhi
Journal:  J Assist Reprod Genet       Date:  2022-02-17       Impact factor: 3.412

3.  Preliminary report of intraovarian injections of autologous platelet-rich plasma (PRP) in extremely poor prognosis patients with only oocyte donation as alternative: a prospective cohort study.

Authors:  D H Barad; D F Albertini; E Molinari; N Gleicher
Journal:  Hum Reprod Open       Date:  2022-06-28

Review 4.  Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI).

Authors:  Bunpei Ishizuka
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

Review 5.  Stem Cell Paracrine Signaling for Treatment of Premature Ovarian Insufficiency.

Authors:  Alba M Polonio; Juan A García-Velasco; Sonia Herraiz
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-24       Impact factor: 5.555

6.  Transcutaneous Ultrasound Guided Intraovarian Injection in Rats (Rattus norvegicus).

Authors:  Etiele M Gomes; Endreo A P Dos Santos; Leonel F L Neto; Danielle R Padilha; Gabrielle C S Campos; Roberto Thiesen; Ingrid R L Machado; Maria Ligia A Mestieri
Journal:  J Am Assoc Lab Anim Sci       Date:  2021-07-19       Impact factor: 1.232

7.  Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency.

Authors:  Abbas Aflatoonian; Marzieh Lotfi; Lida Saeed; Nasim Tabibnejad
Journal:  Reprod Sci       Date:  2021-03-08       Impact factor: 3.060

8.  Reactivating Ovarian Function through Autologous Platelet-Rich Plasma Intraovarian Infusion: Pilot Data on Premature Ovarian Insufficiency, Perimenopausal, Menopausal, and Poor Responder Women.

Authors:  Konstantinos Sfakianoudis; Mara Simopoulou; Sokratis Grigoriadis; Agni Pantou; Petroula Tsioulou; Evangelos Maziotis; Anna Rapani; Polina Giannelou; Nikolaos Nitsos; Georgia Kokkali; Michael Koutsilieris; Konstantinos Pantos
Journal:  J Clin Med       Date:  2020-06-10       Impact factor: 4.241

Review 9.  The Conundrum of Poor Ovarian Response: From Diagnosis to Treatment.

Authors:  Polina Giannelou; Mara Simopoulou; Sokratis Grigoriadis; Evangelos Makrakis; Adamantia Kontogeorgi; Agni Pantou; Dionysios Galatis; Theodoros Kalampokas; Panagiotis Bakas; Stamatis Bolaris; Konstantinos Pantos; Konstantinos Sfakianoudis
Journal:  Diagnostics (Basel)       Date:  2020-09-11

10.  Intraovarian injection of platelet-rich plasma in assisted reproduction: too much too soon?

Authors:  Lloyd Atkinson; Francesca Martin; Roger G Sturmey
Journal:  Hum Reprod       Date:  2021-06-18       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.